ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 25,900 | -32.9% | 0.00% | -100.0% |
| Q1 2022 | $23,000 | 0.0% | 38,600 | -10.4% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | +666.7% | 43,100 | +75.9% | 0.00% | – |
| Q3 2021 | $3,000 | +200.0% | 24,500 | +17.8% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 20,800 | +1.5% | 0.00% | – |
| Q3 2020 | $2,000 | -94.4% | 20,500 | -25.7% | 0.00% | -100.0% |
| Q1 2020 | $36,000 | +140.0% | 27,600 | +33.3% | 0.00% | +100.0% |
| Q4 2019 | $15,000 | – | 20,700 | -79.3% | 0.00% | – |
| Q4 2018 | $0 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |